Freeline Therapeutics (FRLN)

AI Score

Unlock

6.48

0.00 (0.00%)

At close: Feb 16, 2024, 8:59 PM

Freeline Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q2 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	29.45M	38.8M	55.41M	47.28M	65.85M	90M	113.1M	117.66M	136.38M	164.68M	195.76M	229.97M	106.61M	73.7M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	1.33M	1.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.15M	2.22M	2.18M	3.46M	1.89M	3.36M	4.13M	2.92M	2.08M	2.69M	1.66M	1.8M	3.79M	1.03M
Receivables	2.82M	3.12M	1.53M	1.23M	2.96M	2.66M	2.53M	2.21M	17.32M	17.33M	16.74M	16.11M	17.03M	11.5M
Inventory	768K	1.06M	3.77M	17.64M	4.04M	2.14M	4M	6.42M	1.79M	1.56M	1.6M	3.08M	1.93M	842K
Other Current Assets	953K	2.84M	3.15M	1.47M	1.25M	1.31M	2.73M	2M	3.05M	4.73M	9.38M	9.01M	4.31M	3M
Total Current Assets	34M	45.81M	63.87M	67.63M	74.1M	96.11M	122.35M	128.29M	158.54M	188.3M	223.48M	258.18M	129.88M	89.05M
Property-Plant & Equipment	12.55M	14.08M	14.78M	15.02M	22.49M	62.28M	69.69M	9.91M	10.14M	10.05M	10.09M	8.61M	6.75M	7.27M
Goodwill & Intangibles	n/a	n/a	n/a	-1.33M	3K	4K	6K	8K	10K	11K	16K	23K	32K	43K
Total Long-Term Assets	15.22M	16.84M	17.5M	19.01M	25.97M	66.02M	73.82M	12.83M	12.23M	12.75M	11.76M	10.44M	10.58M	8.34M
Total Assets	49.22M	62.65M	81.37M	86.64M	100.08M	162.13M	196.17M	141.13M	170.77M	201.05M	235.25M	268.61M	140.46M	97.39M
Account Payables	7.78M	6.88M	12.45M	10.06M	9.96M	7.88M	9.14M	5.19M	5.67M	4.55M	5.53M	8.09M	12.86M	5.82M
Deferred Revenue	7.13M	8.88M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	2.29M	2.84M	2.75M	2.66M	2.88M	11M	7.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	283K	85K	7.54M	18.25M	9.58M	7.22M	8.84M	15.5M	12.3M	10.87M	10.29M	10.72M	8.62M	6.62M
Total Current Liabilities	17.48M	18.68M	22.74M	30.97M	22.42M	26.1M	25.39M	20.68M	17.97M	15.42M	15.82M	18.81M	21.48M	12.43M
Long-Term Debt	1.7M	1.96M	2.64M	3.26M	9.08M	46.41M	52.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.7M	1.96M	2.64M	3.26M	9.08M	46.41M	52.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	19.18M	20.64M	25.38M	34.23M	31.49M	72.5M	77.61M	20.68M	17.97M	15.42M	15.82M	18.81M	21.48M	12.43M
Total Debt	3.99M	4.8M	5.39M	5.92M	11.96M	57.41M	59.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	137K	137K	137K	137K	137K	n/a	n/a	-9.61M	n/a	n/a	n/a	n/a	153K	n/a
Retained Earnings	-472.29M	-460.2M	-444.19M	-445.35M	-422.35M	-407.46M	-383.11M	-356.38M	-321.68M	-290.81M	-250.94M	-215.99M	-152.93M	-119.67M
Comprehensive Income	-1.57M	-784K	-1.72M	-3.15M	-8.85M	-1.5M	6.74M	9.47M	9.06M	14.2M	11.37M	9.34M	-7.17M	-3M
Shareholders Equity	30.04M	42.02M	55.99M	52.41M	68.58M	89.63M	118.56M	120.44M	152.8M	185.63M	219.43M	249.8M	118.98M	84.96M
Total Investments	n/a	n/a	n/a	1.33M	1.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a